期刊文献+

hTERT启动子调控的CD基因对卵巢癌细胞株的选择性杀伤作用研究 被引量:1

The selective killing effect of CD gene controlled by hTERT promoter on ovarian cancer cells.
下载PDF
导出
摘要 目的探讨由人端粒酶逆转录酶(hTERT)启动子驱动的含胞嘧啶脱氨酶(CD)基因的复制缺陷型腺病毒对卵巢癌细胞的选择性杀伤作用。方法将自行构建的由hTERT启动子调控的携带CD基因的重组腺病毒分别感染人卵巢癌细胞株SKOV3及人胚肺成纤维细胞,通过MTT法检测受染细胞的存活率,观察分析腺病毒载体对细胞的杀伤作用。结果用不同滴度的重组腺病毒以及不同浓度的5-FC作用于SKOV3细胞后,MTT法检测到细胞的存活率随着病毒滴度和5-FC浓度的增加而不断降低;而同样的处理对人胚肺成纤维细胞的也有部分杀伤作用,但远较SKOV3细胞弱,差异有统计学意义(P<0.01)。结论本实验构建的复制缺陷型腺病毒Ad-hTERTp-CD对SKOV3细胞具有靶向杀伤的能力。 Objective To evaluate the selective killing effects of recombinant adenovirus vectors in which the cytosine deaminase( CD )gene is under the control of the human telomerase reverse transcriptase ( hTERT)promoter on ovarian cancer cell in vitro. Metheds SKOV3 cells and human embryo lung fibroblast cells(HELF) transfected with recombined adenovirus were exprosed to medium with 5-FC and MTT assays were performed to measure the cell viabihty. Results After transfected by recombinant adenovirus Ad-hTERTp- CD in vltro,and combined with 5-FC,the cell growth of SKOV3 ovarian cancer cell were suppressed compared with HELF cell( P 〈 0.01 ). Conclusion Recombinant adenovirus combined with 5-FC results in a significant killing effect on SKOV3 cells in vitro, but not on HELF cells.
出处 《四川医学》 CAS 2007年第7期696-698,共3页 Sichuan Medical Journal
关键词 人端粒酶逆转录酶启动子 自杀基因 胞嘧啶脱氨酶基因 腺病毒载体 human telomerase reverse transcriptase( hTERT) suicide gene cytosine deaminase gene adenovirus vector
  • 相关文献

参考文献11

  • 1Majumdar AS,Hughes DE,Lichtsteiner SP,et al.The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters[J].Gene Ther,2001,8(7):568-578
  • 2Braunstein I,Cohen-Barak O,Shachaf C,et al.Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells[J].Cancer Res,2001,61(14):5529-5536
  • 3Gu J,Kagawa S,Takakura M,et al.Tumor-specific transgene expression form the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers[J].Cancer Res,2000,60(19):5359-5364
  • 4Koga S,Hirohata S,Kondo Y,et al.FADD gene therapy using the human telomerase catalytic subunit(hTERT)gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo[J].Anticancer Res,2001,21(3B):1937-1943
  • 5Komata T,Kondo Y,Kanzawa T,et al.Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit(human telomerase reverse transcriptase)gene gromoter[J].Cancer Res,2001,61(15):5796-5802
  • 6Gu J,Andreeff M,Roth JA,et al.hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity[J].Gene Ther,2002,9(1):30-37
  • 7Koga S,Hirohata S,Kondo Y,et al.A novel telomerase-specific gene therapy:gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter[J].Hum Gene Ther,2001,11(10):1397-1406
  • 8Komata T,Kondo Y,Kanzawa T,et al.Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells[J].Hum Gene Ther,2002,13(9):1015-1025
  • 9Komata T,Koga S,Hirohata S,et al.A novel treatment of human malignant gliomas in vitro and in vivo:FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter[J].Int J Oncol,2001,19(5):1015-1020
  • 10Lin T,Huang X,Gu J,et al.Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells[J].Oncogene,2002,21(52):8020-8028

同被引文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部